ReposiTrak (TRAK) EBITDA (2010 - 2025)

ReposiTrak has reported EBITDA for 16 years, with the latest figure at $1.8 million in Q4 2025.

• On a quarterly basis, EBITDA rose 34.38% year-over-year to $1.8 million in Q4 2025; TTM through Dec 2025 was $7.1 million, a 31.21% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 22.23% from the prior year.
• EBITDA was $1.8 million for Q4 2025 at ReposiTrak, down from $1.9 million in the prior quarter.
• The five-year high for EBITDA was $1.9 million in Q3 2025, with the low at $718297.0 in Q1 2021.
• Average EBITDA over 5 years is $1.3 million, with a median of $1.2 million recorded in 2022.
• The sharpest annual moves came in 2021 and 2024: EBITDA soared 203.18% in 2021, then dropped 17.05% in 2024.
• Over 5 years, EBITDA stood at $957569.0 in 2021, then climbed by 22.76% to $1.2 million in 2022, then advanced by 5.56% to $1.2 million in 2023, then advanced by 8.96% to $1.4 million in 2024, then jumped by 34.38% to $1.8 million in 2025.
• The last three EBITDA figures came in at $1.8 million (Q4 2025), $1.9 million (Q3 2025), and $1.6 million (Q2 2025), per Business Quant data.